4-(Difluoromethyl)-3-fluoropyridin-2-amine, 97.0%, 1g

(S)-Methyl 1-methylpyrrolidine-2-carboxylate, 95.0%, 100mg

5-Methoxyisoquinoline-1-carbonitrile, 97%, 250mg

5-chloro-1H-1,3-benzodiazol-6-amine, 98%, 1g

2-(Cyclopropylamino)nicotinic acid, 97.0%, 10g

Thalidomide 4'-oxyacetamide-alkyl-C2-amine (hydrochloride), 100mg

(E)-9-ethyl-3-((2-ethyl-2-(o-tolyl)hydrazono)methyl)-9H-carbazole, 98%, 1g

Methyl 3-Methoxyisobutyrate>98.0%(GC)25mL

Methyl red hydrochloride, 5g

3-Methyl-3,9-diazaspiro[5.5]undecane dihydrochloride, 97%, 10g

sodium 2-(5-sulfanylidene-4,5-dihydro-1H-1,2,3,4-tetrazol-1-yl)acetate, 98%, 250mg

4-Chloro-1H-indole-2-carboxylic acid, 95.0%, 10g

Sodium periodate, min. 99.8%, pa, ACS, 250 g, plastic packaging.